Hendley & CO Inc Becton Dickinson & CO Transaction History

Hendley & CO Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$232.24 - $267.23 $3,483 - $4,008	-15 Reduced 0.29%	5,189 $1.27 Million
Q3 2023 Oct 25, 2023	BUY	$254.9 - $283.59 $689,249 - $766,827	2,704 Added 108.16%	5,204 $1.35 Million
Q4 2022 Jan 24, 2023	SELL	$218.29 - $256.91 $1,746 - $2,055	-8 Reduced 0.32%	2,500 $636,000
Q2 2022 Jul 28, 2022	SELL	$234.74 - $275.42 $23,474 - $27,542	-100 Reduced 3.83%	2,508 $618,000
Q1 2021 Apr 22, 2021	BUY	$232.09 - $256.88 $190,313 - $210,641	820 Added 45.86%	2,608 $634,000
Q3 2020 Oct 21, 2020	BUY	$215.77 - $276.76 $189,877 - $243,548	880 Added 96.92%	1,788 $416,000
Q1 2020 May 05, 2020	SELL	$195.69 - $279.01 $769,061 - $1.1 Million	-3,930 Reduced 81.23%	908 $209,000
Q3 2019 Oct 15, 2019	SELL	$230.58 - $256.08 $73,785 - $81,945	-320 Reduced 6.2%	4,838 $1.22 Million
Q2 2019 Aug 08, 2019	SELL	$217.4 - $246.08 $18,479 - $20,916	-85 Reduced 1.62%	5,158 $1.3 Million
Q1 2019 May 20, 2019	SELL	$206.05 - $248.17 $18,544 - $22,335	-90 Reduced 1.69%	5,243 $1.31 Million
Q3 2018 Oct 29, 2018	SELL	$233.07 - $256.0 $524,873 - $576,512	-2,252 Reduced 29.69%	5,333 $1.39 Million
Q2 2018 Jul 27, 2018	SELL	$208.1 - $233.85 $208 - $233	-1 Reduced 0.01%	7,585 $1.82 Million
Q1 2018 May 08, 2018	SELL	$205.46 - $240.27 $30,819 - $36,040	-150 Reduced 1.94%	7,586 $1.64 Million
Q4 2017 Feb 01, 2018	BUY	$189.0 - $222.64 $64,260 - $75,697	340 Added 4.6%	7,736 $1.66 Million
Q3 2017 Oct 23, 2017	BUY	$186.89 - $198.9 $1.38 Million - $1.47 Million	7,396	7,396 $1.45 Million

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Hendley & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Hendley & CO Inc with notifications on news.